ag真人平台官方
Other Affiliated Sites
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Prospectus
Announcements
2024.04.29
2024 FIRST QUARTERLY REPORT
2024.04.23
Arrangement of Electronic Dissemination of Corporate Communications
2024.04.02
VOLUNTARY ANNOUNCEMENT OBTAINS APPROVAL FROM THAILAND
2024.04.02
INSIDE INFORMATION ANNOUNCEMENT RESULTS OF INDEPENDENT THIRD PARTY INVESTIGATION...
2024.04.02
VOLUNTARY ANNOUNCEMENT “EXARANE” OBTAINS APPROVAL FROM NEW ZEALAND
2024.04.02
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2023
2024.03.15
DATE OF BOARD MEETING
2024.03.15
INSIDE INFORMATION ANNOUNCEMENT
2024.02.01
INSIDE INFORMATION ANNOUNCEMENT COMMENCEMENT OF INDEPENDENT THIRD PARTY INVESTIG...
2024.02.01
PROFIT WARNING ANNOUNCEMENT OF PROPOSED PROVISION FOR INVENTORY IMPAIRMENT IN 20...
第一页
上一页
1
2
3
4
5
下一页
最后一页